Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multicompartment Models: Overview01:14

Multicompartment Models: Overview

113
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
113
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

34
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
34
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

621
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
621
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

72
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
72
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

50
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
50

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HyperDC: A Non-Uniform Hypergraph Framework for Dual- and Higher-Order Drug Combination Recommendation Across Diverse Complex Diseases.

Journal of chemical information and modeling·2026
Same author

MEG-mod: A Multiview Enhanced Graph Neural Network for Knockdown Efficiency Prediction of Chemically Modified siRNA.

Journal of medicinal chemistry·2026
Same author

ULCYP: A Multitask Model for Predicting P450 Inducers Based on Positive-Unlabeled Learning.

Journal of chemical information and modeling·2026
Same author

CypGEM: A Geometry-Aware and Edge-Enhanced Graph Transformer Model for Predicting Sites of Metabolism Mediated by Cytochromes P450.

Journal of chemical information and modeling·2026
Same author

Boosting self-supervised multi-frame depth estimation with hybrid geometric-semantic constraints.

Neural networks : the official journal of the International Neural Network Society·2026
Same author

EviCYP: <i>In Silico</i> Prediction of Cytochrome P450 Substrates Based on Vector Quantization and Evidential Deep Learning.

Journal of chemical information and modeling·2026

Related Experiment Video

Updated: Jun 15, 2025

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

661

Prediction of Cytochrome P450 Substrates Using the Explainable Multitask Deep Learning Models.

Jiaojiao Fang1, Yan Tang1, Changda Gong1

  • 1Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, China.

Chemical Research in Toxicology
|August 28, 2024
PubMed
Summary

Predicting drug metabolism by cytochrome P450 (CYP) enzymes is crucial for drug development. New multitask learning models accurately identify CYP substrates, improving early-stage drug safety assessments.

More Related Videos

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
08:20

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

1.4K
Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

989

Related Experiment Videos

Last Updated: Jun 15, 2025

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

661
Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
08:20

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

1.4K
Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

989

Area of Science:

  • Biochemistry
  • Pharmacology
  • Computational Chemistry

Background:

  • Cytochromes P450 (P450s or CYPs) are critical Phase I metabolic enzymes, processing approximately 75% of therapeutic drugs.
  • CYP-mediated metabolism is linked to toxic metabolite generation and drug-drug interactions, necessitating predictive tools.

Purpose of the Study:

  • To develop and evaluate multitask learning models for simultaneously predicting substrates of five major drug-metabolizing P450 enzymes (CYP3A4, 2C9, 2C19, 2D6, 1A2).
  • To enhance early-stage drug development by accurately identifying potential P450 substrates.

Main Methods:

  • Construction of multitask learning models utilizing fingerprints and graph neural networks.
  • Training and validation on collected substrate datasets for multiple CYP enzymes.
  • Application of Shapley additive explanation and attention mechanisms for substructure identification.

Main Results:

  • The multitask model achieved superior performance, with an average AUC of 90.8% on the test set, outperforming single-task and conventional machine learning models.
  • The model showed robust performance even with limited substrate data for enzymes like CYP1A2, 2C9, and 2C19.
  • Key substructures associated with P450 substrates were identified and validated.

Conclusions:

  • Multitask learning, particularly with graph neural networks, offers a powerful approach for predicting P450 drug metabolism.
  • The developed models provide valuable insights for assessing drug-drug interactions and metabolic liabilities early in drug discovery.
  • Explainability methods aid in understanding the structural basis of P450-substrate interactions.